Unknown

Dataset Information

Nafamostat mesylate has advantages as an anticoagulant for patients undergoing maintenance hemodialysis with conjunctival bleeding


ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC11252668 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature